ID   MYOG_RAT                Reviewed;         287 AA.
AC   P20428;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=Myogenin;
GN   Name=Myog;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2537150; DOI=10.1016/0092-8674(89)90583-7;
RA   Wright W.E., Sassoon D.A., Lin V.K.;
RT   "Myogenin, a factor regulating myogenesis, has a domain homologous to
RT   MyoD.";
RL   Cell 56:607-617(1989).
RN   [2]
RP   INDUCTION.
RX   PubMed=1705035; DOI=10.1073/pnas.88.4.1349;
RA   Eftimie R., Brenner H.R., Buonanno A.;
RT   "Myogenin and MyoD join a family of skeletal muscle genes regulated by
RT   electrical activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1349-1353(1991).
RN   [3]
RP   INTERACTION WITH CSRP3.
RX   PubMed=9234731; DOI=10.1128/mcb.17.8.4750;
RA   Kong Y., Flick M.J., Kudla A.J., Konieczny S.F.;
RT   "Muscle LIM protein promotes myogenesis by enhancing the activity of
RT   MyoD.";
RL   Mol. Cell. Biol. 17:4750-4760(1997).
RN   [4]
RP   FUNCTION, PHOSPHORYLATION AT SER-77; SER-79 AND THR-87, DNA-BINDING, AND
RP   MUTAGENESIS OF SER-77; SER-79 AND THR-87.
RX   PubMed=14751541; DOI=10.1016/j.cellsig.2003.09.006;
RA   Tang H., Macpherson P., Argetsinger L.S., Cieslak D., Suhr S.T.,
RA   Carter-Su C., Goldman D.;
RT   "CaM kinase II-dependent phosphorylation of myogenin contributes to
RT   activity-dependent suppression of nAChR gene expression in developing rat
RT   myotubes.";
RL   Cell. Signal. 16:551-563(2004).
CC   -!- FUNCTION: Acts as a transcriptional activator that promotes
CC       transcription of muscle-specific target genes and plays a role in
CC       muscle differentiation, cell cycle exit and muscle atrophy. Essential
CC       for the development of functional embryonic skeletal fiber muscle
CC       differentiation. However is dispensable for postnatal skeletal muscle
CC       growth; phosphorylation by CAMK2G inhibits its transcriptional activity
CC       in respons to muscle activity. Required for the recruitment of the FACT
CC       complex to muscle-specific promoter regions, thus promoting gene
CC       expression initiation. During terminal myoblast differentiation, plays
CC       a role as a strong activator of transcription at loci with an open
CC       chromatin structure previously initiated by MYOD1. Together with MYF5
CC       and MYOD1, co-occupies muscle-specific gene promoter core regions
CC       during myogenesis. Cooperates also with myocyte-specific enhancer
CC       factor MEF2D and BRG1-dependent recruitment of SWI/SNF chromatin-
CC       remodeling enzymes to alter chromatin structure at myogenic late gene
CC       promoters. Facilitates cell cycle exit during terminal muscle
CC       differentiation through the up-regulation of miR-20a expression, which
CC       in turn represses genes involved in cell cycle progression. Binds to
CC       the E-box containing (E1) promoter region of the miR-20a gene. Plays
CC       also a role in preventing reversal of muscle cell differentiation.
CC       Contributes to the atrophy-related gene expression in adult denervated
CC       muscles. Induces fibroblasts to differentiate into myoblasts.
CC       {ECO:0000269|PubMed:14751541}.
CC   -!- SUBUNIT: Homodimer and heterodimer with E12; heterodimerization
CC       enhances MYOG DNA-binding and transcriptional activities. Interacts
CC       with SMARCA4/BRG1/BAF190A. Interacts (via C-terminal region) with SSRP1
CC       and SUPT16H; the interaction is indicative of an interaction with the
CC       FACT complex (By similarity). Interacts with CSRP3. {ECO:0000250,
CC       ECO:0000269|PubMed:9234731}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Recruited to late myogenic gene
CC       promoter regulatory sequences with SMARCA4/BRG1/BAF190A and SWI/SNF
CC       chromatin-remodeling enzymes to promote chromatin-remodeling and
CC       transcription initiation in developing embryos. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in muscle (at protein level).
CC   -!- INDUCTION: Up-regulated in denerved muscles cells. Down-regulated in
CC       soleus muscle in an electrical activity-dependent manner.
CC       {ECO:0000269|PubMed:1705035}.
CC   -!- PTM: Phosphorylated by CAMK2G on threonine and serine amino acids in a
CC       muscle activity-dependent manner. Phosphorylation of Thr-87 impairs
CC       both DNA-binding and trans-activation functions in contracting muscles.
CC       {ECO:0000269|PubMed:14751541}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M24393; AAA41662.1; -; mRNA.
DR   PIR; A31876; A31876.
DR   RefSeq; NP_058811.2; NM_017115.2.
DR   AlphaFoldDB; P20428; -.
DR   SMR; P20428; -.
DR   DIP; DIP-52N; -.
DR   STRING; 10116.ENSRNOP00000073308; -.
DR   iPTMnet; P20428; -.
DR   PhosphoSitePlus; P20428; -.
DR   PaxDb; 10116-ENSRNOP00000039817; -.
DR   GeneID; 29148; -.
DR   KEGG; rno:29148; -.
DR   UCSC; RGD:620432; rat.
DR   AGR; RGD:620432; -.
DR   CTD; 4656; -.
DR   RGD; 620432; Myog.
DR   eggNOG; KOG3960; Eukaryota.
DR   HOGENOM; CLU_969646_0_0_1; -.
DR   InParanoid; P20428; -.
DR   OrthoDB; 5392786at2759; -.
DR   PhylomeDB; P20428; -.
DR   TreeFam; TF316344; -.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   PRO; PR:P20428; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000030743; Expressed in quadriceps femoris and 3 other cell types or tissues.
DR   ExpressionAtlas; P20428; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0071285; P:cellular response to lithium ion; ISO:RGD.
DR   GO; GO:0071259; P:cellular response to magnetism; IEP:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0042692; P:muscle cell differentiation; ISO:RGD.
DR   GO; GO:0007517; P:muscle organ development; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; IEP:RGD.
DR   GO; GO:0014902; P:myotube differentiation; IMP:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; IDA:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0014737; P:positive regulation of muscle atrophy; ISS:UniProtKB.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0010831; P:positive regulation of myotube differentiation; ISS:UniProtKB.
DR   GO; GO:1903862; P:positive regulation of oxidative phosphorylation; IDA:RGD.
DR   GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:1901739; P:regulation of myoblast fusion; ISS:UniProtKB.
DR   GO; GO:0014842; P:regulation of skeletal muscle satellite cell proliferation; ISS:UniProtKB.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:UniProtKB.
DR   GO; GO:0014878; P:response to electrical stimulus involved in regulation of muscle adaptation; IDA:UniProtKB.
DR   GO; GO:0009629; P:response to gravity; IEP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; IDA:UniProtKB.
DR   GO; GO:0014732; P:skeletal muscle atrophy; IEP:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IBA:GO_Central.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEP:RGD.
DR   GO; GO:0014891; P:striated muscle atrophy; ISS:UniProtKB.
DR   CDD; cd18935; bHLH_TS_MYOG_Myf4; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR002546; MyoD_N.
DR   InterPro; IPR039704; Myogenic_factor.
DR   PANTHER; PTHR11534; MYOGENIC FACTOR; 1.
DR   PANTHER; PTHR11534:SF5; MYOGENIN; 1.
DR   Pfam; PF01586; Basic; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00520; BASIC; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Activator; Cell cycle; Developmental protein; Differentiation; DNA-binding;
KW   Myogenesis; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..287
FT                   /note="Myogenin"
FT                   /id="PRO_0000127378"
FT   DOMAIN          81..132
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   MOD_RES         77
FT                   /note="Phosphoserine; by CaMK2G"
FT                   /evidence="ECO:0000269|PubMed:14751541"
FT   MOD_RES         79
FT                   /note="Phosphoserine; by CaMK2G"
FT                   /evidence="ECO:0000269|PubMed:14751541"
FT   MOD_RES         87
FT                   /note="Phosphothreonine; by CaMK2G"
FT                   /evidence="ECO:0000269|PubMed:14751541"
FT   MUTAGEN         77
FT                   /note="S->A: Reduces phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:14751541"
FT   MUTAGEN         79
FT                   /note="S->A: Reduces phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:14751541"
FT   MUTAGEN         87
FT                   /note="T->A: Reduces phosphorylation and inhibits DNA-
FT                   binding and transcriptional activation."
FT                   /evidence="ECO:0000269|PubMed:14751541"
SQ   SEQUENCE   287 AA;  32503 MW;  BE454E59B1464B40 CRC64;
     MELYETSPYF YQEPHFYDGE NYLPVHLQGF EPPGYERTEL SLSPEARGPL EEKGLGTPEH
     CPGQCLPWAC KVCKRKSVSV DRRRAATLRE KRRLKKVNEA FEALKRSTLL NPNQRLPKVE
     ILRSAIQYIE RLQALLSSLN QEERDLRYRG GGGPSRWYPV NATPTAPPAV RSGAMHWSLV
     PTQEIICSQL TLQVPTTCTP LRPSWTASRW RICLSPSQMK PCPTEIVCQA GCAWEPLSWC
     QTPPLLQQGP FKWGCPGAQK TALGCHKPDY PPSIHIRLTP SPAREFN
//
